Lars Gusch, CEO of Pharmacolog i Uppsala AB (publ) presented the company's new strategic direction at Småbolagsdagarna, June 12th, 2023.
Pharmacolog paves the way for strong commercial development. By broadening the distribution network and introducing a SaaS model to lower the initial investment, more hospitals can implement quality control of compounded pharmaceuticals and thereby increase patient safety.
The live streamed event was arranged by Aktiespararna and the presentation (in Swedish) has been made available on the company website https://pharmacolog.com/investor-relations-2/.